compensation rates of medical staff secured for the future business expansion. Financing Costs The Company and its subsidiary’s financing costs in relation to the loans from financial institutions and related
), representing 89.12% of the total issued and outstanding shares in Permata (the Transaction) in accordance with the resolution of the Board of Directors’ Meeting No. 12/2019, given on 11 December 2019. Each of
5.88 -13% 23.62 21.17 12% Financing cost 3.58 0.03 11583% 12.03 3.01 300% Tax (Note) 7.81 15.82 -51% 56.44 26.45 113% Net profit 70.04 58.29 20% 258.16 255.91 1% % Net profit margin 18% 16% 2% 16% 18% -2
with InsurTech platform. For the operation of debt management last year, the Company acquire distress debt amount 21,003 million Baht in term of outstanding balance of bad debt. The Company’s strategy is
change of the liabilities was the repayment of long-term loan amounting to 618 MTHB. As at 31 December 2017, the Company and its subsidiaries had no loan outstanding compared to 2016. Analysis of
by Baht 9.82 million or 7.80% from 2016 as a result of the 2016 tax payment and fully payment 2016 outstanding liabilities which occurred from construction of Phra Nakorn Sri Ayutthaya Branch. 3
5.41% from 2016 mainly from decrease in accrued tax as a result of 2016 tax payment and fully payment 2016 outstanding liabilities which occurred from construction of Phra Nakorn Sri Ayutthaya Branch. 3
depreciation 21% 24% -3% 24% 24% 0% Other income /(expenses) 4.72 4.81 -2% 14.20 10.29 38% Financing cost 4.32 1.15 275% 4.62 2.40 93% Tax (Note) 13.71 10.53 30% 31.53 (7.94) -497% Net profit 43.96 49.00 -10
depreciation 27% 29% -2% 25% 26% -1% Other income /(expenses) 4.33 5.00 -13% 18.53 15.29 21% Financing cost 3.83 0.58 556% 8.45 2.98 184% Tax (Note) 17.10 18.57 -8% 48.63 10.64 357% Net profit 75.08 74.43 1